I-many (NASDAQ:IMNY) delivers advanced enterprise contract management solution for managing corporate commitments. I-many comprehensive solutions have enabled more than 280 customers worldwide to manage contracts and obligations to payment and collections, allowing them to ensure transaction compliance, increase revenues and maximize ROI. With 22 of the top 25 pharmaceutical companies as customers, I-many's life science solution suites automate all aspects of commercial and government contract processes including rebate and incentives management, collections and deductions, compliance monitoring, pricing optimization, and analytics. The results are optimized contract development process and higher contract revenues.

PricewaterhouseCoopers, a global leader in serving the pharmaceutical and life sciences industry, has extensive experience in working with companies on industry-specific strategic, operational and financial issues. Our services include assurance, tax and advisory services. Our advisory practice works with clients to address a broad range of performance and process improvement, compliance and risk management challenges in the areas of R&D, manufacturing, and sales and marketing. For more information, visit our website at